317 related articles for article (PubMed ID: 25165192)
1. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
Seystahl K; Tritschler I; Szabo E; Tabatabai G; Weller M
Neuro Oncol; 2015 Feb; 17(2):254-65. PubMed ID: 25165192
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells.
Tang Y; Yang X; Friesel RE; Vary CP; Liaw L
J Vasc Res; 2011; 48(6):485-94. PubMed ID: 21832838
[TBL] [Abstract][Full Text] [Related]
3. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-β signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts.
Schwartze JT; Becker S; Sakkas E; Wujak ŁA; Niess G; Usemann J; Reichenberger F; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
J Biol Chem; 2014 Feb; 289(6):3262-75. PubMed ID: 24347165
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.
Zhang H; Du L; Zhong Y; Flanders KC; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L615-L627. PubMed ID: 28642261
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.
Grönroos E; Kingston IJ; Ramachandran A; Randall RA; Vizán P; Hill CS
Mol Cell Biol; 2012 Jul; 32(14):2904-16. PubMed ID: 22615489
[TBL] [Abstract][Full Text] [Related]
7. TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK.
Bakkebø M; Huse K; Hilden VI; Smeland EB; Oksvold MP
BMC Immunol; 2010 Nov; 11():57. PubMed ID: 21092277
[TBL] [Abstract][Full Text] [Related]
8. Bioreactor-Controlled Physoxia Regulates TGF-β Signaling to Alter Extracellular Matrix Synthesis by Human Chondrocytes.
Jahr H; Gunes S; Kuhn AR; Nebelung S; Pufe T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959909
[TBL] [Abstract][Full Text] [Related]
9. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC.
Lee NY; Ray B; How T; Blobe GC
J Biol Chem; 2008 Nov; 283(47):32527-33. PubMed ID: 18775991
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
Daly AC; Randall RA; Hill CS
Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
[TBL] [Abstract][Full Text] [Related]
11. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
[TBL] [Abstract][Full Text] [Related]
13. A tumor-promoting role for soluble TβRIII in glioblastoma.
Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
[TBL] [Abstract][Full Text] [Related]
14. Activation of TGF-β receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice.
Vecerova L; Strasky Z; Rathouska J; Slanarova M; Brcakova E; Micuda S; Nachtigal P
J Atheroscler Thromb; 2012; 19(2):115-26. PubMed ID: 22104174
[TBL] [Abstract][Full Text] [Related]
15. Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions.
Itoh F; Itoh S; Adachi T; Ichikawa K; Matsumura Y; Takagi T; Festing M; Watanabe T; Weinstein M; Karlsson S; Kato M
Blood; 2012 May; 119(22):5320-8. PubMed ID: 22498737
[TBL] [Abstract][Full Text] [Related]
16. Canonical Wnt signaling skews TGF-β signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8.
van den Bosch MH; Blom AB; van Lent PL; van Beuningen HM; Blaney Davidson EN; van der Kraan PM; van den Berg WB
Cell Signal; 2014 May; 26(5):951-8. PubMed ID: 24463008
[TBL] [Abstract][Full Text] [Related]
17. Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.
Oh MK; Joo H; Kim IS
PLoS One; 2022; 17(5):e0266409. PubMed ID: 35580109
[TBL] [Abstract][Full Text] [Related]
18. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
[TBL] [Abstract][Full Text] [Related]
19. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.
Akool el-S; Doller A; Müller R; Gutwein P; Xin C; Huwiler A; Pfeilschifter J; Eberhardt W
J Biol Chem; 2005 Nov; 280(47):39403-16. PubMed ID: 16183640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
